Literature DB >> 20413972

What does 'non-inferior to' really mean? A clinician thinking out loud.

Stefano Ricci1.   

Abstract

As clinicians, we are frequently faced with papers stating that something is 'non-inferior' to something else. By definition, a non-inferiority trial aims to demonstrate that the test product is not worse than the comparator by more than a small pre-specified amount. This amount is known as the non-inferiority margin, or delta. Clinicians must know who has chosen the margin, and why. Only when the advantages of the trial treatment clearly overcome the amount of 'worsening' which is implicit in the concept of non-inferiority and delta can we recommend this new 'non-inferior' (or, rather, 'just a little bit worse') treatment to our patients. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20413972     DOI: 10.1159/000312869

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  2 in total

1.  Fractional flow reserve-guided PCI as compared with coronary bypass surgery (FAME III)- another brick in the wall!

Authors:  Pradeep Narayan
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2022-04-05

2.  Non-inferiority clinical trials: Practical issues and current regulatory perspective.

Authors:  Sandeep K Gupta
Journal:  Indian J Pharmacol       Date:  2011-07       Impact factor: 1.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.